Congress Shouldn't Ignore GAO's Counsel on PBMs

Members of the Senate Finance Committee recently introduced a bill to place more restrictions on how pharmacy benefit managers (PBMs) — the groups that health plans utilize to administer their prescription drug programs — manage Medicare Part D. Unfortunately, their legislation does not adequately consider the Government Accountability Office’s (GAO) past and pending findings concerning the utility PBMs provide in lowering federal entitlement spending.


Read Full Article »

Show comments Hide Comments

Related Articles

Market Overview
Search Stock Quotes